Showing results (11-20 of 781) with videos related to

Sort By:
Pageof 79
British Journal of Haematology|September 10, 2011
Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disordersJooeun Bae, Yu-Tzu Tai, Kenneth C Anderson, et al.
Cancers|December 10, 2021
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple MyelomaShih-Feng Cho, Lijie Xing, Kenneth C Anderson, et al.
Expert Opinion on Investigational Drugs|February 22, 2014
Daratumumab granted breakthrough drug statusJacob P Laubach, Yu-Tzu Tai, Paul G Richardson, et al.
Frontiers in Oncology|November 4, 2022
Bispecific antibodies in multiple myeloma treatment: A journey in progressShih-Feng Cho, Tsung-Jang Yeh, Kenneth C Anderson, et al.
Leukemia|August 30, 2019
Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myelomaArghya Ray, Yan Song, Ting Du, et al.
Experimental Hematology & Oncology|July 21, 2017
Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target eraLi Zhang, Yu-Tzu Tai, Matthew Zhi Guang Ho, et al.
Expert Opinion on Emerging Drugs|March 3, 2009
Emerging therapies for multiple myelomaKlaus Podar, Yu-Tzu Tai, Teru Hideshima, et al.
Blood Cancer Journal|April 2, 2022
Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myelomaArghya Ray, Yan Song, Ting Du, et al.
Blood|February 7, 2002
CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cellsYu-Tzu Tai, Klaus Podar, Deepak Gupta, et al.
Cancers|June 11, 2020
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.
Pageof 79